Growth Metrics

Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Zimmer Biomet Holdings has reported Asset Writedowns and Impairment over the past 7 years, most recently at $289.8 million for Q4 2022.

  • For Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million; the TTM value through Dec 2022 reached $292.8 million, up 332.94%, while the annual FY2022 figure was $292.8 million, 1696.32% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2022 was $289.8 million at Zimmer Biomet Holdings, up from $3.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $975.9 million in Q4 2018 and troughed at -$142.0 million in Q4 2020.
  • A 5-year average of $206.9 million and a median of $33.0 million in 2020 define the central range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 258.79% in 2018 and fell as far as 88.38% in 2018.
  • Year by year, Asset Writedowns and Impairment stood at $975.9 million in 2018, then tumbled by 92.82% to $70.1 million in 2019, then plummeted by 302.57% to -$142.0 million in 2020, then surged by 111.48% to $16.3 million in 2021, then skyrocketed by 1677.91% to $289.8 million in 2022.
  • Business Quant data shows Asset Writedowns and Impairment for ZBH at $289.8 million in Q4 2022, $3.0 million in Q2 2022, and $16.3 million in Q2 2021.